Jerusik R J, Kadis S, Chapman W L, Wooley R E
Can J Microbiol. 1977 Oct;23(10):1448-55. doi: 10.1139/m77-213.
The role of Corynebacterium renale urease in the establishment of pyelonephritis was studied by the oral administration of acetohydroxamic acid (AHA), a urease inhibitor, to experimentally infected rats. The bacteria were introduced by surgical insertion of a zinc disc containing 1 X 10(6) colony-forming units of C-renale into the urinary bladder whereas sterile discs were implanted in the bladders of the control animals. Daily administration of AHA via the drinking water did not halt the development of pyelonephritis. Larger doses, given by gavage, did accomplish this goal; that is, the pH of the urine was lowered, the number of colony-forming units of C. renale in the kidney was reduced drastically, and pyelonephritic lesions were observed in the kidney by light-microscopic examination. All experimental rats developed cystitis in varying degrees of severity. About 70% of the intact AHA given by gavage was excreted in the urine 24 h after administration of this compound. Rats implanted with a urease-negative mutant of C. renale displayed no signs of pyelonephritis but did develop cystitis.
通过给实验性感染的大鼠口服乙酰氧肟酸(AHA,一种脲酶抑制剂),研究了肾棒状杆菌脲酶在肾盂肾炎发病过程中的作用。通过手术将含有1×10⁶个肾棒状杆菌菌落形成单位的锌盘植入膀胱来接种细菌,而对照动物的膀胱中植入无菌盘。通过饮水每日给予AHA并不能阻止肾盂肾炎的发展。通过灌胃给予更大剂量则能实现这一目标;也就是说,尿液pH值降低,肾脏中肾棒状杆菌的菌落形成单位数量大幅减少,并且通过光学显微镜检查在肾脏中观察到了肾盂肾炎病变。所有实验大鼠均出现了不同程度的膀胱炎。灌胃给予的完整AHA约70%在给药后24小时经尿液排出。植入肾棒状杆菌脲酶阴性突变体的大鼠未表现出肾盂肾炎的迹象,但确实出现了膀胱炎。